We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are OK with this.     OK  No, I would like to know more...
Home / About Novasep / Media & Events / Press releases

Press releases

Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep

Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep

15 Jan 2021

Expanded global capacity addresses growing demand for cell and gene therapy


Novasep to sell its chromatography equipment division to Sartorius

Novasep to sell its chromatography equipment division to Sartorius

06 Jan 2021

• A disposal aligned with Novasep’s core strategy
• An opportunity for Novasep’s chromatography equipment division to accelerate its growth by joining an established leader in the sector


The French bioproduction sector announces the creation of Campus Biotech Digital,  a platform unique in the world for bioproduction training

Covid-19 vaccine candidate:  Novasep signs a Master Supply and Development Agreement with AstraZeneca

Novasep invests €6.5 million to expand capacity and increase flexibility in an API manufacturing workshop at its Chasse-sur-Rhône site (69 – France)

Novasep invests €6.5 million to expand capacity and increase flexibility in an API manufacturing workshop at its Chasse-sur-Rhône site (69 – France)

10 Nov 2020

Novasep announces a €6.5 million investment to upgrade an API manufacturing workshop at its Chasse-sur-Rhône site (69 - France)


Novasep and Handl Therapeutics announce signature of a gene therapy product development and manufacturing agreement

Novasep and Handl Therapeutics announce signature of a gene therapy product development and manufacturing agreement

02 Nov 2020

This agreement covers the development and manufacturing of an Adeno-Associated Virus (AAV) based gene therapy drug candidate for the treatment of neurodegenerative diseases


Sensorion and Novasep announce signature of a gene therapy product development and manufacturing agreement

Sensorion and Novasep announce signature of a gene therapy product development and manufacturing agreement

26 Oct 2020

• Agreement covers the development and manufacturing of AAV vectors, a key step for Sensorion’s gene therapy programs
• Agreement secures drug product development and manufacturing capacity for the Company’s Otoferlin program
• Gene therapy could revolutionize the treatment of genetic inner ear disorders


Frontier Biotech chooses Novasep HPLC chromatography columns and skids for peptide purification on its Nanjing (China) site

Frontier Biotech chooses Novasep HPLC chromatography columns and skids for peptide purification on its Nanjing (China) site

08 Jul 2020

Novasep, a leading supplier of services and technologies for the life sciences industry, announces Frontier Biotechnologies Inc. (“Frontier Biotech”) chooses Novasep Prochrom® HPLC chromatography columns and skids for its Nanjing (China) site.


Coronavirus: NOVASEP partners with ASTRAZENECA to produce Covid-19 Oxford vaccine for Europe

Coronavirus: NOVASEP partners with ASTRAZENECA to produce Covid-19 Oxford vaccine for Europe

15 Jun 2020

Novasep will produce the active substance of the vaccine in its Belgian facilities


 NOVASEP and LYSOGENE Announce their New Collaboration for Development and Production of GM1 Gangliosidosis Gene Therapy Product

NOVASEP and LYSOGENE Announce their New Collaboration for Development and Production of GM1 Gangliosidosis Gene Therapy Product

25 May 2020

This agreement covers the manufacturing of the Adeno-Associated Virus (AAV)



You can stay on this page and select more documents or you can directly download the brochure(s) you selected
Give us your feedback!